Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000 in Adults in the Metropolitan and Non-metropolitan areas in the United States, 1999 to 2... by Aman Goyal (19231397)

Subjects:

Hematological parameters. by Nida Saleem (17194610)

Subjects:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by Census Regions in Adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Relationship between dissipation energy and elastic strain energy. by Yongsheng Liu (142720)

Subjects:

(A) Overall cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000 in Adults in the United States, 1999 to 2022, and (B) Sex-Stratified cardiov... by Aman Goyal (19231397)

Subjects:

Mechanical parameter trends under different chemical environments and wet-dry cycles. by Yongsheng Liu (142720)

Subjects:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by State in Adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

ZTRE-210 Microcomputer Control Rock Triaxial Test System. by Yongsheng Liu (142720)

Subjects:

Marble specimens. by Yongsheng Liu (142720)

Subjects:

Mechanical parameters of marble under different chemical environments and dry-wet cycle conditions. by Yongsheng Liu (142720)

Subjects:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by ethnoracial groups in Adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Comparison of Cardiovascular-kidney-metabolic syndrome-related-related Average Age-Adjusted Mortality Rates (AAMRs) per 1,000,000 during the COVID-19 Pandemic period (2020-2022) wi... by Aman Goyal (19231397)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against laboratory-confirmed infections during the different waves. by Rima Moghnieh (679199)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against acute-care hospitalization attributed to laboratory-confirmed infections during the differen... by Rima Moghnieh (679199)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.4/BA.5 variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. by Rima Moghnieh (679199)

Subjects:

Fig 4 - by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects: